Shoko Kawai

Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Yasuhiro Kato, Yukio Hosomi, Kageaki Watanabe et al. · Journal of Thoracic Disease · 2019 · 54 citations · Full text

Medicine, Oncology, Pharmacology +13

Management of Cardiac Tamponade During Nivolumab Of Lung Cancer with Intrapericardial Bleomycin: Case Report

Maiko Asai, Yasuhiro Kato, Shoko Kawai et al. · Immunotherapy · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study)

Shogo Nomura, Yasushi Goto, Tomonori Mizutani et al. · Japanese Journal of Clinical Oncology · 2020 · 25 citations · Full text

Medicine, Oncology, Pharmacology +14

Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy

Yuji Uehara, Taiki Hakozaki, Rui Kitadai et al. · Translational Lung Cancer Research · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prognostic Implication of Cellular DNA Content in Acute Lymphoblastic Leukemia

Masahito Tsurusawa, N Katano, Shoko Kawai et al. · Journal of Pediatric Hematology/Oncology · 1988 · 11 citations

Medicine, Hematology, Oncology +17